Jana Tchekalarova Selected Research

Jana Tchekalarova Research Topics

Disease

22	Seizures (Absence Seizure) 02/2022 - 01/2005
19	Epilepsy (Aura) 04/2021 - 10/2004
14	Status Epilepticus (Complex Partial Status Epilepticus) 02/2022 - 04/2013
7	Temporal Lobe Epilepsy 01/2022 - 02/2011
5	Inflammation (Inflammations) 02/2022 - 01/2018
4	Cognitive Dysfunction 01/2022 - 04/2018
4	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2021 - 01/2005
3	Neuroinflammatory Diseases 02/2022 - 04/2021
3	Alzheimer Disease (Alzheimer's Disease) 11/2021 - 01/2019
3	Hypertension (High Blood Pressure) 01/2018 - 10/2013
1	Sleep Initiation and Maintenance Disorders (Insomnia) 10/2022
1	Hypercholesterolemia 03/2022
1	Body Weight (Weight, Body) 01/2022
1	Anhedonia 01/2020
1	Gliosis 01/2018
1	Nervous System Diseases (Neurological Disorders) 10/2015
1	Apnea 05/2007

Drug/Important Bio-Agent (IBA)

12	Kainic Acid (Kainate)IBA 02/2022 - 02/2011
10	MelatoninIBA 10/2022 - 04/2013
9	Anticonvulsants (Antiepileptic Drugs)IBA 02/2022 - 08/2017
6	agomelatine (S20098)IBA 10/2021 - 08/2017
6	Caffeine (No Doz)FDA LinkGeneric 12/2013 - 04/2006
4	Peptides (Polypeptides)IBA 02/2022 - 01/2019
4	AntioxidantsIBA 02/2022 - 10/2013
4	Pilocarpine (Ocusert)FDA LinkGeneric 01/2022 - 12/2020
4	Antidepressive Agents (Antidepressants)IBA 10/2021 - 08/2017
3	Topiramate (Topamax)FDA LinkGeneric 01/2022 - 12/2020
3	Lacosamide FDA Link 04/2021 - 12/2020
3	Pentylenetetrazole (Metrazol)IBA 09/2009 - 01/2005
2	indoleIBA 02/2022 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 02/2022 - 01/2019
2	Sucrose (Saccharose)IBA 04/2021 - 01/2020
2	VV-hemorphin-5IBA 11/2019 - 01/2019
2	AcidsIBA 01/2018 - 08/2017
2	Dopamine (Intropin)FDA LinkGeneric 05/2015 - 10/2004
2	Serotonin (5 Hydroxytryptamine)IBA 05/2015 - 04/2013
2	AngiotensinsIBA 05/2015 - 01/2005
2	BicucullineIBA 05/2007 - 01/2005
2	PicrotoxinIBA 05/2007 - 01/2005
2	des-Asp(1)-des-Arg(2)-Ile(5)- angiotensin IIIBA 01/2005 - 10/2004
1	N- (2- (5- methoxy- indol- 3- yl)- ethyl)- 4- oxo- 4H- pyran- 2- carboxamideIBA 10/2022
1	HMGB1 Protein (HMG1)IBA 02/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	Amyloid (Amyloid Fibrils)IBA 11/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2021
1	VV-hemorphin-7IBA 04/2020
1	salicylhydroxamic acid (SHAM)IBA 01/2020
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 11/2019
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019
1	Streptozocin (Streptozotocin)FDA Link 01/2019
1	Amino Acids FDA Link 01/2019
1	Amyloid beta-PeptidesIBA 01/2019
1	CB2 Cannabinoid ReceptorIBA 04/2018
1	Malondialdehyde (Propanedial)IBA 04/2018
1	caryophylleneIBA 04/2018
1	Losartan (Cozaar)FDA LinkGeneric 01/2018
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2018
1	Type 1 Angiotensin ReceptorIBA 01/2018
1	CorticosteroneIBA 01/2018
1	InterleukinsIBA 01/2018
1	Serotonin AntagonistsIBA 08/2017
1	MT2 Melatonin ReceptorIBA 08/2017
1	Neurotransmitter Agents (Neurotransmitter)IBA 05/2015
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 05/2015
1	NAD (NADH)IBA 05/2015
1	ZD 7155IBA 05/2015
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 10/2013
1	Drinking WaterIBA 04/2013
1	methylxanthineIBA 10/2010
1	Glutamate Receptors (Glutamate Receptor)IBA 02/2010
1	Aminophylline (Carine)FDA LinkGeneric 05/2007
1	ConvulsantsIBA 05/2007
1	Neuroprotective AgentsIBA 01/2005
1	3-Mercaptopropionic Acid (3 Mercaptopropionic Acid)IBA 01/2005

Therapy/Procedure

3	Pinealectomy 03/2022 - 01/2020
2	Therapeutics 11/2021 - 10/2013
1	Drug Therapy (Chemotherapy) 11/2016